Bristol-Myers Squibb Financial Health
Profitability:8.59/10
✅ Bristol-Myers Squibb has better Profitability than 85.71% of the companies on the Drug Manufacturers industry
Net Margin: 23.39%
✅ Bristol-Myers Squibb has better Net Margin than 71.43% of the companies on the Drug Manufacturers industry
ROE (Return on Equity): 8.98%
✅ Bristol-Myers Squibb has better ROE (Return on Equity) than 83.33% of the companies on the Drug Manufacturers industry
ROA (Return on Assets): 3.1%
✅ Bristol-Myers Squibb has better ROA (Return on Assets) than 85.71% of the companies on the Drug Manufacturers industry
Operating Efficiency:9.74/10
✅ Bristol-Myers Squibb has better Operating Efficiency than 57.14% of the companies on the Drug Manufacturers industry
Operating Margin: 51.11%
✅ Bristol-Myers Squibb has better Operating Margin than 57.14% of the companies on the Drug Manufacturers industry
Liquidity:8.98/10
✅ Bristol-Myers Squibb has better Liquidity than 85.71% of the companies on the Drug Manufacturers industry
Quick Ratio: 3.72
✅ Bristol-Myers Squibb has better Quick Ratio than 85.71% of the companies on the Drug Manufacturers industry
Operating Cash Flow Ratio: 0.81
✅ Bristol-Myers Squibb has better Operating Cash Flow Ratio than 71.43% of the companies on the Drug Manufacturers industry
Solvency:5.84/10
❌ Bristol-Myers Squibb has worst Solvency than 85.71% of the companies on the Drug Manufacturers industry
Debt to Equity Ratio: 1.41
❌ Bristol-Myers Squibb has worst Debt to Equity Ratio than 85.71% of the companies on the Drug Manufacturers industry
Interest Coverage Ratio: 0.81
✅ Bristol-Myers Squibb has better Interest Coverage Ratio than 71.43% of the companies on the Drug Manufacturers industry